Functional variants of -1318T > G and -673C > T in c-Jun promoter region associated with increased colorectal cancer risk by elevating promoter activity

Carcinogenesis

Volumn 32, Issue 7, 2011, Pages 1043-1049

  Chen, Dianke ^a   Song, Shunxin ^a   Lu, Jiachun ^b   Luo, Yanxin ^a   Yang, Zuli ^a   Huang, Qinghua ^a   Fu, Xinhui ^a   Fan, Xinjuan ^a   Wei, Yisheng ^b   Wang, Jianping ^a   Wang, Lei ^a  

^a THE SIXTH AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^b GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN C JUN;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER RISK; COLORECTAL CANCER; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 79960046212     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgr047     Document Type: Article

References (45)

1. Jemal,A. et al. (2010) Cancer statistics, 2010. CA Cancer J. Clin., 60, 277-300.
2. Parkin,D.M. et al. (2005) Global cancer statistics, 2002. CA Cancer J. Clin., 55, 74-108.
3. Yee,Y.K. et al. (2009) Epidemiology of colorectal cancer in Asia. J. Gastroenterol. Hepatol., 24, 1810-1816.
4. Zhao,P. et al. (2010) Cancer trends in China. Jpn. J. Clin. Oncol., 40, 281-285.
5. Cao,K.J. et al. (2009) [Incidence of colorectal cancer in Guangzhou City from 2000 to 2002]. Ai Zheng, 28, 441-444.
6. Ji,B.T. et al. (1998) Colorectal cancer incidence trends by subsite in urban Shanghai, 1972-1994. Cancer Epidemiol. Biomarkers Prev., 7, 661-666.
7. Fearon,E.R. et al. (1990) A genetic model for colorectal tumorigenesis. Cell, 61, 759-767.
8. Colditz,G.A. et al. (2006) Epidemiology - identifying the causes and preventability of cancer? Nat. Rev. Cancer., 6, 75-83.
9. Ogino,S.. et al. (2011) Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field. Gut, 60, 397-411.
10. Botteri,E. et al. (2008) Smoking and colorectal cancer: a meta-analysis. JAMA, 300, 2765-2778.
11. Thygesen,L.C. et al. (2008) Alcohol intake and colorectal cancer - A comparison of approaches for including repeated measures of alcohol consumption. Epidemiology, 19, 258-264.
12. Huxley,R.R. et al. (2009) The impact of dietary and lifestyle risk factors on risk of colorectal cancer: a quantitative overview of the epidemiological evidence. Int. J. Cancer., 125, 171-180.
13. Wang,Y. et al. (2008) A prospective study of waist circumference and body mass index in relation to colorectal cancer incidence. Cancer Causes Control, 19, 783-792.
14. Lichtenstein,P. et al. (2000) Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland. N. Engl. J. Med., 343, 78-85.
15. Ahmed,F.E. (2006) Gene-gene, gene-environment & multiple interactions in colorectal cancer. J. Environ. Sci. Health C Environ. Carcinog. Ecotoxicol. Rev., 24, 1-101.
16. Fang,J.Y. et al. (2005) The MAPK signalling pathways and colorectal cancer. Lancet Oncol., 6, 322-327.
17. Chung,D.C. (2000) The genetic basis of colorectal cancer: insights into critical pathways of tumorigenesis. Gastroenterology, 119, 854-865.
18. Mechta,F. et al. (1997) Transformation by ras modifies AP1 composition and activity. Oncogene, 14, 837-847.
19. Maki,Y. et al. (1987) Avian sarcoma virus 17 carries the jun oncogene. Proc. Natl Acad. Sci. USA., 84, 2848-2852.
20. Haluska,F.G. et al. (1988) Localization of the human JUN protooncogene to chromosome region 1p31-32. Proc. Natl Acad. Sci. USA., 85, 2215-2218.
21. Lee,S.Y. et al. (2004) Transcriptional regulation of Zic3 by heterodimeric AP-1(c-Jun/c-Fos) during Xenopus development. Exp. Mol. Med., 36, 468-475.
22. Hilberg,F. et al. (1993) c-jun is essential for normal mouse development and hepatogenesis. Nature, 365, 179-181.
23. Johnson,R.S. et al. (1993) A null mutation at the c-jun locus causes embryonic lethality and retarded cell growth in culture. Genes Dev., 7, 1309-1317.
24. Schreiber,M. et al. (1999) Control of cell cycle progression by c-Jun is p53 dependent. Genes Dev., 13, 607-619.
25. Wisdom,R. et al. (1999) c-Jun regulates cell cycle progression and apoptosis by distinct mechanisms. EMBO J., 18, 188-197.
26. Bos,T.J. et al. (1999) Enhanced cell motility and invasion of chicken embryo fibroblasts in response to Jun over-expression. Int. J. Cancer., 81, 404-410.
27. Smith,L.M. et al. (1999) cJun overexpression in MCF-7 breast cancer cells produces a tumorigenic, invasive and hormone resistant phenotype. Oncogene, 18, 6063-6070.
28. Young,M.R. et al. (1999) Transgenic mice demonstrate AP-1 (activator protein-1) transactivation is required for tumor promotion. Proc. Natl Acad. Sci. USA., 96, 9827-9832.
29. Wei,Y. et al. (2009) The association between -1304T.G polymorphism in the promoter of MKK4 gene and the risk of sporadic colorectal cancer in southern Chinese population. Int. J. Cancer., 125, 1876-1883.
30. Liu,B. et al. (2010) A functional variant (-1304T.G) in the MKK4 promoter contributes to a decreased risk of lung cancer by increasing the promoter activity. Carcinogenesis, 31, 1405-1411.
31. Zhou,B.F. (2002) Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults-study on optimal cut-off points of body mass index and waist circumference in Chinese adults. Biomed. Environ. Sci., 15, 83-96.
32. Eferl,R. et al. (2003) AP-1: a double-edged sword in tumorigenesis. Nat. Rev. Cancer., 3, 859-868.
33. Hess,J. et al. (2004) AP-1 subunits: quarrel and harmony among siblings. J. Cell Sci., 117, 5965-5973.
34. Shaulian,E. et al. (2000) The mammalian UV response: c-jun induction is required for exit from p53-imposed growth arrest. Cell, 103, 897-907.
35. Zhang,W. et al. (2005) Differential expression of the AP-1 transcription factor family members in human colorectal epithelial and neuroendocrine neoplasms. Am. J. Clin. Pathol., 124, 11-19.
36. Wang,H. et al. (2000) Expression of Jun family members in human colorectal adenocarcinoma. Carcinogenesis, 21, 1313-1317.
37. Suto,R. et al. (2002) Dominant. negative mutant of c-Jun gene transfer suppressed cell proliferation of colon cancer HT-29 in vitro. Gastroenterology, 122, A237.
38. Suto,R. et al. (2004) Dominant-negative mutant of c-Jun gene transfer: a novel therapeutic strategy for colorectal cancer. Gene Ther., 11, 187-193.
39. Akey,J. et al. (2001) Haplotypes vs single marker linkage disequilibrium tests: what do we gain? Eur. J. Hum. Genet., 9, 291-300.
40. Johnson,G.C. et al. (2001) Haplotype tagging for the identification of common disease genes. Nat. Genet., 29, 233-237.
41. Rozen,P. et al. (2011) The changing epidemiology of colorectal cancer and its relevance for adapting screening guidelines and methods. Eur. J. Cancer Prev., 20, 46-53.
42. Lampe,J.W. et al. (1993) Sex differences in colonic function: a randomised trial. Gut, 34, 531-536.
43. Campagnoli,C. et al. (1993) Differential effects of oral conjugated estrogens and transdermal estradiol on insulin-like growth factor 1, growth hormone and sex hormone binding globulin serum levels. Gynecol. Endocrinol., 7, 251-258.
44. Chlebowski,R.T. et al. (2004) Estrogen plus progestin and colorectal cancer in postmenopausal women. N. Engl. J. Med., 350, 991-1004.
45. Wacholder,S. et al. (2004) Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J. Natl Cancer Inst., 96, 434-442.